Back to search
Refractory Cancer Pain
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Refractory Cancer Pain trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Refractory Cancer Pain trials you may qualify forThis study will examine the safety of giving the experimental drug, resiniferatoxin (RTX), to treat severe pain in patients with advanced cancer. RTX is a chemi…
The overall objective of this study is to assess the feasibility, safety and preliminary efficacy of psilocybin-assisted therapy to alleviate opioid-refractory…
The main objective of this study is to analyze the impact on the health-related quality of life of patients with refractory symptoms, who have been referred to…
Background: Cancer-induced bone pain (CIBP) is common in people with cancer. Bone cancer can also lead to anxiety, depression, and reduced mobility and quality…
This trial aims to address refractory cancer pain (RCP). It will explore the synergistic efficacy and safety of hydromorphone hydrochloride sustained-release ta…